Chemoinformaics analysis of RETUSIN 7-O-NEOHESPERIDOSIDE
| Molecular Weight | 592.55 | nRot | 7 |
| Heavy Atom Molecular Weight | 560.294 | nRig | 30 |
| Exact Molecular Weight | 592.179 | nRing | 5 |
| Solubility: LogS | -3.925 | nHRing | 3 |
| Solubility: LogP | -0.458 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 2 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 14 | No. of Arom Bond | 17 |
| nHA | 14 | APOL | 79.3254 |
| nHD | 7 | BPOL | 43.3866 |
| QED | 0.179 |
| Synth | 4.586 |
| Natural Product Likeliness | 1.821 |
| NR-PPAR-gamma | 0.805 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.983 |
| HIA | 0.942 |
| CACO-2 | -6.335 |
| MDCK | 0.0000833 |
| BBB | 0.249 |
| PPB | 0.713137 |
| VDSS | 0.658 |
| FU | 0.173452 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.052 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.101 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.271 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.208 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.017 |
| CL | 1.354 |
| T12 | 0.17 |
| hERG | 0.013 |
| Ames | 0.458 |
| ROA | 0.106 |
| SkinSen | 0.019 |
| Carcinogencity | 0.706 |
| EI | 0.005 |
| Respiratory | 0.019 |
| NR-Aromatase | 0.913 |
| Antiviral | Yes |
| Prediction | 0.858828 |